GENIUS SPORTS LTD (GENI) Fundamental Analysis & Valuation

NYSE:GENI • GG00BMF1JR16

5.275 USD
+0.07 (+1.25%)
Last: Mar 12, 2026, 01:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This GENI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

GENI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 126 industry peers in the Hotels, Restaurants & Leisure industry. GENI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GENI is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. GENI Profitability Analysis

1.1 Basic Checks

  • In the past year GENI has reported negative net income.
  • In the past year GENI had a positive cash flow from operations.
  • In the past 5 years GENI always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: GENI reported negative operating cash flow in multiple years.
GENI Yearly Net Income VS EBIT VS OCF VS FCFGENI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M

1.2 Ratios

  • GENI's Return On Assets of -9.87% is on the low side compared to the rest of the industry. GENI is outperformed by 85.71% of its industry peers.
  • GENI has a Return On Equity of -15.40%. This is in the lower half of the industry: GENI underperforms 61.11% of its industry peers.
Industry RankSector Rank
ROA -9.87%
ROE -15.4%
ROIC N/A
ROA(3y)-9.62%
ROA(5y)-24.09%
ROE(3y)-13.78%
ROE(5y)-31.67%
ROIC(3y)N/A
ROIC(5y)N/A
GENI Yearly ROA, ROE, ROICGENI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • The Gross Margin of GENI (22.98%) is worse than 83.33% of its industry peers.
  • In the last couple of years the Gross Margin of GENI has grown nicely.
  • The Profit Margin and Operating Margin are not available for GENI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y200.08%
GM growth 5YN/A
GENI Yearly Profit, Operating, Gross MarginsGENI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. GENI Health Analysis

2.1 Basic Checks

  • GENI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • GENI has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GENI has been increased compared to 5 years ago.
  • GENI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GENI Yearly Shares OutstandingGENI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
GENI Yearly Total Debt VS Total AssetsGENI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • GENI has an Altman-Z score of 0.85. This is a bad value and indicates that GENI is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.85, GENI is not doing good in the industry: 69.84% of the companies in the same industry are doing better.
  • There is no outstanding debt for GENI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.85
ROIC/WACCN/A
WACC9.57%
GENI Yearly LT Debt VS Equity VS FCFGENI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.56 indicates that GENI should not have too much problems paying its short term obligations.
  • GENI's Current ratio of 1.56 is fine compared to the rest of the industry. GENI outperforms 70.63% of its industry peers.
  • GENI has a Quick Ratio of 1.56. This is a normal value and indicates that GENI is financially healthy and should not expect problems in meeting its short term obligations.
  • GENI's Quick ratio of 1.56 is fine compared to the rest of the industry. GENI outperforms 75.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
GENI Yearly Current Assets VS Current LiabilitesGENI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. GENI Growth Analysis

3.1 Past

  • The earnings per share for GENI have decreased strongly by -59.26% in the last year.
  • Looking at the last year, GENI shows a very strong growth in Revenue. The Revenue has grown by 31.04%.
  • The Revenue has been growing by 25.22% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-59.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)31.04%
Revenue growth 3Y25.22%
Revenue growth 5YN/A
Sales Q2Q%37.01%

3.2 Future

  • GENI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 73.68% yearly.
  • The Revenue is expected to grow by 20.03% on average over the next years. This is a very strong growth
EPS Next Y132.47%
EPS Next 2Y73.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year28.41%
Revenue Next 2Y28.39%
Revenue Next 3Y15.83%
Revenue Next 5Y20.03%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
GENI Yearly Revenue VS EstimatesGENI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B
GENI Yearly EPS VS EstimatesGENI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

2

4. GENI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GENI. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 37.78, the valuation of GENI can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GENI is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.27, GENI is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 37.78
GENI Price Earnings VS Forward Price EarningsGENI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, GENI is valued a bit more expensive than the industry average as 61.11% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 242.82
EV/EBITDA N/A
GENI Per share dataGENI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

  • GENI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • GENI's earnings are expected to grow with 73.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.68%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GENI Dividend Analysis

5.1 Amount

  • GENI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GENI Fundamentals: All Metrics, Ratios and Statistics

GENIUS SPORTS LTD

NYSE:GENI (3/12/2026, 1:44:08 PM)

5.275

+0.07 (+1.25%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-04
Earnings (Next)05-04
Inst Owners98.79%
Inst Owner Change0.71%
Ins Owners8.07%
Ins Owner ChangeN/A
Market Cap1.34B
Revenue(TTM)669.49M
Net Income(TTM)-111.58M
Analysts82.4
Price Target12.78 (142.27%)
Short Float %5.96%
Short Ratio2.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1558.58%
Min EPS beat(2)-2756.23%
Max EPS beat(2)-360.92%
EPS beat(4)1
Avg EPS beat(4)-1071.76%
Min EPS beat(4)-2756.23%
Max EPS beat(4)16.89%
EPS beat(8)2
Avg EPS beat(8)-619.22%
EPS beat(12)2
Avg EPS beat(12)-425.95%
EPS beat(16)4
Avg EPS beat(16)-342.27%
Revenue beat(2)2
Avg Revenue beat(2)2.24%
Min Revenue beat(2)0.65%
Max Revenue beat(2)3.82%
Revenue beat(4)2
Avg Revenue beat(4)0.18%
Min Revenue beat(4)-2.01%
Max Revenue beat(4)3.82%
Revenue beat(8)3
Avg Revenue beat(8)-0.31%
Revenue beat(12)5
Avg Revenue beat(12)0.43%
Revenue beat(16)7
Avg Revenue beat(16)1.18%
PT rev (1m)-18.25%
PT rev (3m)-16.9%
EPS NQ rev (1m)2.93%
EPS NQ rev (3m)16%
EPS NY rev (1m)56.1%
EPS NY rev (3m)6.94%
Revenue NQ rev (1m)0.87%
Revenue NQ rev (3m)1.85%
Revenue NY rev (1m)7.68%
Revenue NY rev (3m)11.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 37.78
P/S 2
P/FCF 242.82
P/OCF 15.46
P/B 1.84
P/tB 5.51
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)0.14
Fwd EY2.65%
FCF(TTM)0.02
FCFY0.41%
OCF(TTM)0.34
OCFY6.47%
SpS2.64
BVpS2.86
TBVpS0.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.87%
ROE -15.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.98%
FCFM 0.82%
ROA(3y)-9.62%
ROA(5y)-24.09%
ROE(3y)-13.78%
ROE(5y)-31.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y200.08%
GM growth 5YN/A
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 114.71%
Cap/Sales 12.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z 0.85
F-Score4
WACC9.57%
ROIC/WACCN/A
Cap/Depr(3y)88.94%
Cap/Depr(5y)78.48%
Cap/Sales(3y)12.19%
Cap/Sales(5y)12.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y132.47%
EPS Next 2Y73.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.04%
Revenue growth 3Y25.22%
Revenue growth 5YN/A
Sales Q2Q%37.01%
Revenue Next Year28.41%
Revenue Next 2Y28.39%
Revenue Next 3Y15.83%
Revenue Next 5Y20.03%
EBIT growth 1Y-151.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year300.45%
EBIT Next 3Y69.73%
EBIT Next 5Y57.91%
FCF growth 1Y-68.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.54%
OCF growth 3YN/A
OCF growth 5YN/A

GENIUS SPORTS LTD / GENI FAQ

What is the ChartMill fundamental rating of GENIUS SPORTS LTD (GENI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to GENI.


What is the valuation status for GENI stock?

ChartMill assigns a valuation rating of 2 / 10 to GENIUS SPORTS LTD (GENI). This can be considered as Overvalued.


How profitable is GENIUS SPORTS LTD (GENI) stock?

GENIUS SPORTS LTD (GENI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for GENI stock?

The Earnings per Share (EPS) of GENIUS SPORTS LTD (GENI) is expected to grow by 132.47% in the next year.